Correlation Between Visa and Helix BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and Helix BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Helix BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Inc CDR and Helix BioPharma Corp, you can compare the effects of market volatilities on Visa and Helix BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Helix BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Helix BioPharma.

Diversification Opportunities for Visa and Helix BioPharma

-0.77
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Visa and Helix is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Visa Inc CDR and Helix BioPharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Helix BioPharma Corp and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Inc CDR are associated (or correlated) with Helix BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Helix BioPharma Corp has no effect on the direction of Visa i.e., Visa and Helix BioPharma go up and down completely randomly.

Pair Corralation between Visa and Helix BioPharma

Assuming the 90 days trading horizon Visa is expected to generate 1.81 times less return on investment than Helix BioPharma. But when comparing it to its historical volatility, Visa Inc CDR is 5.9 times less risky than Helix BioPharma. It trades about 0.07 of its potential returns per unit of risk. Helix BioPharma Corp is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  110.00  in Helix BioPharma Corp on September 1, 2024 and sell it today you would lose (23.00) from holding Helix BioPharma Corp or give up 20.91% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Visa Inc CDR  vs.  Helix BioPharma Corp

 Performance 
       Timeline  
Visa Inc CDR 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Inc CDR are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating technical and fundamental indicators, Visa exhibited solid returns over the last few months and may actually be approaching a breakup point.
Helix BioPharma Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Helix BioPharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Visa and Helix BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and Helix BioPharma

The main advantage of trading using opposite Visa and Helix BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Helix BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Helix BioPharma will offset losses from the drop in Helix BioPharma's long position.
The idea behind Visa Inc CDR and Helix BioPharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Content Syndication
Quickly integrate customizable finance content to your own investment portal